Responsive image

Common name


Rasagiline

IUPAC name


(1R)-N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine

SMILES


C#CCN[C@@H]1CCC2=CC=CC=C12

Compound class


Neuroprotective Agents; Monoamine Oxidase Inhibitors; Nervous System; Anti-Parkinson Drugs; Dopaminergic Agents; Monoamine Oxidase B Inhibitors; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers;

Therapeutic area


For the treatment of the signs and symptoms of idiopathic Parkinsons disease as initial monotherapy and as adjunct therapy to levodopa.

Common name


Rasagiline

IUPAC name


(1R)-N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine

SMILES


C#CCN[C@@H]1CCC2=CC=CC=C12

INCHI


InChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1

FORMULA


C12H13N

Responsive image

Common name


Rasagiline

IUPAC name


(1R)-N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine

Molecular weight


171.238

clogP


2.847

clogS


-2.925

HBond Acceptor


0

HBond Donor


1

Total Polar
Surface Area


12.03

Number of Rings


2

Rotatable Bond


3

Drug ID Common name Structure CAS SMILE Frequency
FDBF01877 prop-1-yne Responsive image C#CC 0.0082
FDBF02360 prop-2-yn-1-amine Responsive image NCC#C 0.0007
FDBF02991 (1R)-indan-1-amine Responsive image C1(CCc2c1cccc2)N 0.0003
FDBF02992 (1R)-N-methylindan-1-amine Responsive image C1(CCc2c1cccc2)NC 0.0003
4 , 1